Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Aug;3(8):849-54.
doi: 10.1158/2326-6066.CIR-15-0100. Epub 2015 Jun 29.

Ablation of B7-H3 but Not B7-H4 Results in Highly Increased Tumor Burden in a Murine Model of Spontaneous Prostate Cancer

Affiliations

Ablation of B7-H3 but Not B7-H4 Results in Highly Increased Tumor Burden in a Murine Model of Spontaneous Prostate Cancer

Katharina Kreymborg et al. Cancer Immunol Res. 2015 Aug.

Abstract

The costimulatory molecules B7-H3 and B7-H4 are overexpressed in a variety of human tumors and have been hypothesized as possible biomarkers and immunotherapeutic targets. Despite this potential, the predominating uncertainty about their functional implication in tumor-host interaction hampers their evaluation as a target for cancer therapy. By means of a highly physiologic, spontaneous tumor model in mice, we establish a causal link between B7-H3 and host tumor control and found B7-H4 to be redundant.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Greatly increased growth of murine prostate tumors in the absence of B7-H3
(a) B7-H3 and (b) B7-H4 mRNA expression in the DL prostate lobes of male TRAMP+ or age-matched TRAMP littermate control mice at indicated time points measured by qPCR and calculated by 2(-ΔΔ Ct) ± SEM . (n≥3 per group) (c) Representative images of UG of 18-week and (d) 30-week old TRAMP+wt, TRAMP+B7-H3−/− and age-matched TRAMPwt or TRAMPB7-H3−/− littermate control mice, respectively. (e) Masses of UG and DL prostates of TRAMP+wt, TRAMP+B7-H3−/−, TRAMP+B7-H4−/− and corresponding TRAMPwt, TRAMPB7-H3−/− or TRAMPB7-H4−/− littermate control mice, respectively, evaluated at 12 weeks, (f) 18 weeks and (g) 30 weeks of age and normalized to whole body weight ±SEM. (TRAMP+wt: n=39, TRAMP+B7-H3−/−: n=48, TRAMP+B7-H4−/−: n=21, TRAMPwt: n=33, TRAMPB7-H3−/−: n=28, TRAMPB7-H4−/−: n=14) Unpaired t test. * p< 0.05, ** p< 0.01, *** p< 0.001.
Figure 2
Figure 2. Lack of B7-H3 expression on radio-resistant tissue accounts for elevated tumor growth and accumulation of regulatory FoxP3+ T cells
Percentages of tumor-infiltrating (a) FoxP3+ cells and (b) Ki67+FoxP3+ cells, (c) total FoxP3+ cell-counts per mg of tumor, and (d) ratio of FoxP3+ to CD8+ T cells isolated from TRAMP+wt and TRAMP+B7-H3−/− tumors at 18 weeks of age and analyzed by flow cytometry ± SEM (n≥5). Masses of (e) UG and (f) DL prostates of indicated bone marrow chimeric TRAMP+wt, TRAMP+B7-H3−/− and corresponding TRAMP control mice evaluated at 30 weeks of age and normalized to whole body weight ±SEM (TRAMP+: n≥6). Percentages of tumor-infiltrating (g) FoxP3+ cells and (f) Ki67+FoxP3+ cells isolated from indicated bone marrow chimeric TRAMP+ mice at 30 weeks of age. Unpaired t test. * p< 0.05, ** p< 0.01, *** p< 0.001, **** p<0.0001

References

    1. Kaplan DH, Shankaran V, Dighe AS, Stockert E, Aguet M, Old LJ, et al. Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. Proc Natl Acad Sci USA. 1998;95:7556–7561. - PMC - PubMed
    1. Shankaran V, Ikeda H, Bruce AT, White JM, Swanson PE, Old LJ, et al. IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature. 2001;410:1107–1111. - PubMed
    1. Peggs KS, Quezada SA, Allison JP. Cancer immunotherapy: co-stimulatory agonists and co-inhibitory antagonists. Clin Exp Immunol. 2009;157:9–19. - PMC - PubMed
    1. Hodi FS, O'Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med. 2010;363:711–723. - PMC - PubMed
    1. Loos M, Hedderich DM, Friess H, Kleeff J. B7-h3 and its role in antitumor immunity. Clin Dev Immunol. 2010;2010:683875. - PMC - PubMed

Publication types

MeSH terms